These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2818141)

  • 1. Alprazolam augmentation of antipsychotic pharmacotherapy?
    Thienhaus OJ; Somoza E; Nobilski M
    Arch Gen Psychiatry; 1989 Nov; 46(11):1052-3. PubMed ID: 2818141
    [No Abstract]   [Full Text] [Related]  

  • 2. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results.
    Wolkowitz OM; Breier A; Doran A; Kelsoe J; Lucas P; Paul SM; Pickar D
    Arch Gen Psychiatry; 1988 Jul; 45(7):664-71. PubMed ID: 3289524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
    Douyon R; Angrist B; Peselow E; Cooper T; Rotrosen J
    Am J Psychiatry; 1989 Feb; 146(2):231-4. PubMed ID: 2563211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.
    Wolkowitz OM; Pickar D; Doran AR; Breier A; Tarell J; Paul SM
    Am J Psychiatry; 1986 Jan; 143(1):85-7. PubMed ID: 2867690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alprazolam augmentation of neuroleptics in schizophrenia.
    Wolkowitz OM; Breier A; Doran A; Lucas P; Kelsoe J; Paul SM; Pickar D
    Am J Psychiatry; 1989 Aug; 146(8):1087-8. PubMed ID: 2568762
    [No Abstract]   [Full Text] [Related]  

  • 6. Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia.
    Barbee JG; Mancuso DM; Freed CR; Todorov AA
    Am J Psychiatry; 1992 Apr; 149(4):506-10. PubMed ID: 1348161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alprazolam-neuroleptic combination in schizophrenia.
    Lipinski JF; Cohen BM
    Am J Psychiatry; 1986 Nov; 143(11):1501-2. PubMed ID: 2877587
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined alprazolam and neuroleptic drug in treating schizophrenia.
    Bacher NM; Lewis HA; Field PB
    Am J Psychiatry; 1986 Oct; 143(10):1311-3. PubMed ID: 2876649
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluphenazine activity and antipsychotic response.
    Hitzemann RJ; Garver DL; Mavroidis M; Hirschowitz J; Zemlan FP
    Psychopharmacology (Berl); 1986; 90(2):270-3. PubMed ID: 3097710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications.
    Kahn JP; Puertollano MA; Schane MD; Klein DF
    Am J Psychiatry; 1988 Jun; 145(6):742-4. PubMed ID: 2897166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is there a special indication for fluphenazine in therapy refractory hallucinations?].
    Bechter K
    Nervenarzt; 1994 Nov; 65(11):798-801. PubMed ID: 7816159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.
    Litman RE; Hong WW; Weissman EM; Su TP; Potter WZ; Pickar D
    J Clin Psychopharmacol; 1993 Aug; 13(4):264-7. PubMed ID: 8104200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazepam treatment of early signs of exacerbation in schizophrenia.
    Carpenter WT; Buchanan RW; Kirkpatrick B; Breier AF
    Am J Psychiatry; 1999 Feb; 156(2):299-303. PubMed ID: 9989567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical response to clozapine in patients with schizophrenia.
    Pickar D; Litman RE; Hong WW; Su TP; Weissman EM; Hsiao JK; Potter WZ
    Arch Gen Psychiatry; 1994 Feb; 51(2):159-60. PubMed ID: 8297214
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G; Annable L; Ross-Chouinard A
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract]   [Full Text] [Related]  

  • 16. Benzodiazepines in schizophrenia: prefrontal cortex atrophy predicts clinical response to alprazolam augmentation.
    Seeley WW; Turetsky N; Reus VI; Wolkowitz OM
    World J Biol Psychiatry; 2002 Oct; 3(4):221-4. PubMed ID: 12516314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
    Raskind M; Alvarez C; Herlin S
    J Am Geriatr Soc; 1979 Oct; 27(10):459-63. PubMed ID: 469146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms.
    Csernansky JG; Riney SJ; Lombrozo L; Overall JE; Hollister LE
    Arch Gen Psychiatry; 1988 Jul; 45(7):655-9. PubMed ID: 3289523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA; Aderounmu AF
    J Clin Psychiatry; 1982 May; 43(5):195-6. PubMed ID: 7076630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia.
    Marder SR; Wirshing WC; Van Putten T; Mintz J; McKenzie J; Johnston-Cronk K; Lebell M; Liberman RP
    Arch Gen Psychiatry; 1994 Apr; 51(4):280-7. PubMed ID: 8161288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.